Repurposed Drugs Market - Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: R7E076237F28EN
Market Monitor Global

Abstracts

Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.

This report contains market size and forecasts of Repurposed Drugs in Global, including the following market information:

Global Repurposed Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Repurposed Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Generic Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Repurposed Drugs include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, Bausch Health, GSK, ChemRar Group and Glenmark, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Repurposed Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Repurposed Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Repurposed Drugs Market Segment Percentages, by Type, 2021 (%)

• Generic Drugs
• Clinical Trial Failed Drugs

Global Repurposed Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Repurposed Drugs Market Segment Percentages, by Application, 2021 (%)

• Cardiovascular Diseases
• Mental Illness
• Cancer
• Other

Global Repurposed Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Repurposed Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Repurposed Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Repurposed Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva
• Novartis
• Mylan
• Johnson & Johnson
• Pfizer
• Bausch Health
• GSK
• ChemRar Group
• Glenmark
• Fujifilm
• Dr. Reddy
• R-Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Repurposed Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Repurposed Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL REPURPOSED DRUGS OVERALL MARKET SIZE

2.1 Global Repurposed Drugs Market Size: 2021 VS 2028
2.2 Global Repurposed Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Repurposed Drugs Players in Global Market
3.2 Top Global Repurposed Drugs Companies Ranked by Revenue
3.3 Global Repurposed Drugs Revenue by Companies
3.4 Top 3 and Top 5 Repurposed Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Repurposed Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Repurposed Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Repurposed Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Repurposed Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Repurposed Drugs Market Size Markets, 2021 & 2028
  4.1.2 Generic Drugs
  4.1.3 Clinical Trial Failed Drugs
4.2 By Type - Global Repurposed Drugs Revenue & Forecasts
  4.2.1 By Type - Global Repurposed Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Repurposed Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Repurposed Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Repurposed Drugs Market Size, 2021 & 2028
  5.1.2 Cardiovascular Diseases
  5.1.3 Mental Illness
  5.1.4 Cancer
  5.1.5 Other
5.2 By Application - Global Repurposed Drugs Revenue & Forecasts
  5.2.1 By Application - Global Repurposed Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Repurposed Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Repurposed Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Repurposed Drugs Market Size, 2021 & 2028
6.2 By Region - Global Repurposed Drugs Revenue & Forecasts
  6.2.1 By Region - Global Repurposed Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Repurposed Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Repurposed Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Repurposed Drugs Revenue, 2017-2028
  6.3.2 US Repurposed Drugs Market Size, 2017-2028
  6.3.3 Canada Repurposed Drugs Market Size, 2017-2028
  6.3.4 Mexico Repurposed Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Repurposed Drugs Revenue, 2017-2028
  6.4.2 Germany Repurposed Drugs Market Size, 2017-2028
  6.4.3 France Repurposed Drugs Market Size, 2017-2028
  6.4.4 U.K. Repurposed Drugs Market Size, 2017-2028
  6.4.5 Italy Repurposed Drugs Market Size, 2017-2028
  6.4.6 Russia Repurposed Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Repurposed Drugs Market Size, 2017-2028
  6.4.8 Benelux Repurposed Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Repurposed Drugs Revenue, 2017-2028
  6.5.2 China Repurposed Drugs Market Size, 2017-2028
  6.5.3 Japan Repurposed Drugs Market Size, 2017-2028
  6.5.4 South Korea Repurposed Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Repurposed Drugs Market Size, 2017-2028
  6.5.6 India Repurposed Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Repurposed Drugs Revenue, 2017-2028
  6.6.2 Brazil Repurposed Drugs Market Size, 2017-2028
  6.6.3 Argentina Repurposed Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Repurposed Drugs Revenue, 2017-2028
  6.7.2 Turkey Repurposed Drugs Market Size, 2017-2028
  6.7.3 Israel Repurposed Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Repurposed Drugs Market Size, 2017-2028
  6.7.5 UAE Repurposed Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Teva
  7.1.1 Teva Corporate Summary
  7.1.2 Teva Business Overview
  7.1.3 Teva Repurposed Drugs Major Product Offerings
  7.1.4 Teva Repurposed Drugs Revenue in Global Market (2017-2022)
  7.1.5 Teva Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Repurposed Drugs Major Product Offerings
  7.2.4 Novartis Repurposed Drugs Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Mylan
  7.3.1 Mylan Corporate Summary
  7.3.2 Mylan Business Overview
  7.3.3 Mylan Repurposed Drugs Major Product Offerings
  7.3.4 Mylan Repurposed Drugs Revenue in Global Market (2017-2022)
  7.3.5 Mylan Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Repurposed Drugs Major Product Offerings
  7.4.4 Johnson & Johnson Repurposed Drugs Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Repurposed Drugs Major Product Offerings
  7.5.4 Pfizer Repurposed Drugs Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Bausch Health
  7.6.1 Bausch Health Corporate Summary
  7.6.2 Bausch Health Business Overview
  7.6.3 Bausch Health Repurposed Drugs Major Product Offerings
  7.6.4 Bausch Health Repurposed Drugs Revenue in Global Market (2017-2022)
  7.6.5 Bausch Health Key News
7.7 GSK
  7.7.1 GSK Corporate Summary
  7.7.2 GSK Business Overview
  7.7.3 GSK Repurposed Drugs Major Product Offerings
  7.7.4 GSK Repurposed Drugs Revenue in Global Market (2017-2022)
  7.7.5 GSK Key News
7.8 ChemRar Group
  7.8.1 ChemRar Group Corporate Summary
  7.8.2 ChemRar Group Business Overview
  7.8.3 ChemRar Group Repurposed Drugs Major Product Offerings
  7.8.4 ChemRar Group Repurposed Drugs Revenue in Global Market (2017-2022)
  7.8.5 ChemRar Group Key News
7.9 Glenmark
  7.9.1 Glenmark Corporate Summary
  7.9.2 Glenmark Business Overview
  7.9.3 Glenmark Repurposed Drugs Major Product Offerings
  7.9.4 Glenmark Repurposed Drugs Revenue in Global Market (2017-2022)
  7.9.5 Glenmark Key News
7.10 Fujifilm
  7.10.1 Fujifilm Corporate Summary
  7.10.2 Fujifilm Business Overview
  7.10.3 Fujifilm Repurposed Drugs Major Product Offerings
  7.10.4 Fujifilm Repurposed Drugs Revenue in Global Market (2017-2022)
  7.10.5 Fujifilm Key News
7.11 Dr. Reddy
  7.11.1 Dr. Reddy Corporate Summary
  7.11.2 Dr. Reddy Business Overview
  7.11.3 Dr. Reddy Repurposed Drugs Major Product Offerings
  7.11.4 Dr. Reddy Repurposed Drugs Revenue in Global Market (2017-2022)
  7.11.5 Dr. Reddy Key News
7.12 R-Pharma
  7.12.1 R-Pharma Corporate Summary
  7.12.2 R-Pharma Business Overview
  7.12.3 R-Pharma Repurposed Drugs Major Product Offerings
  7.12.4 R-Pharma Repurposed Drugs Revenue in Global Market (2017-2022)
  7.12.5 R-Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Repurposed Drugs Market Opportunities & Trends in Global Market
Table 2. Repurposed Drugs Market Drivers in Global Market
Table 3. Repurposed Drugs Market Restraints in Global Market
Table 4. Key Players of Repurposed Drugs in Global Market
Table 5. Top Repurposed Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Repurposed Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Repurposed Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Repurposed Drugs Product Type
Table 9. List of Global Tier 1 Repurposed Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Repurposed Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Repurposed Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Repurposed Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Repurposed Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Repurposed Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Repurposed Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Repurposed Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Repurposed Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Repurposed Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Repurposed Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Repurposed Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Repurposed Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Repurposed Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Repurposed Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Repurposed Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Repurposed Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Repurposed Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Repurposed Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Repurposed Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Repurposed Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Teva Corporate Summary
Table 31. Teva Repurposed Drugs Product Offerings
Table 32. Teva Repurposed Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Repurposed Drugs Product Offerings
Table 35. Novartis Repurposed Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Mylan Corporate Summary
Table 37. Mylan Repurposed Drugs Product Offerings
Table 38. Mylan Repurposed Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Repurposed Drugs Product Offerings
Table 41. Johnson & Johnson Repurposed Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Repurposed Drugs Product Offerings
Table 44. Pfizer Repurposed Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Bausch Health Corporate Summary
Table 46. Bausch Health Repurposed Drugs Product Offerings
Table 47. Bausch Health Repurposed Drugs Revenue (US$, Mn), (2017-2022)
Table 48. GSK Corporate Summary
Table 49. GSK Repurposed Drugs Product Offerings
Table 50. GSK Repurposed Drugs Revenue (US$, Mn), (2017-2022)
Table 51. ChemRar Group Corporate Summary
Table 52. ChemRar Group Repurposed Drugs Product Offerings
Table 53. ChemRar Group Repurposed Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Glenmark Corporate Summary
Table 55. Glenmark Repurposed Drugs Product Offerings
Table 56. Glenmark Repurposed Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Fujifilm Corporate Summary
Table 58. Fujifilm Repurposed Drugs Product Offerings
Table 59. Fujifilm Repurposed Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Dr. Reddy Corporate Summary
Table 61. Dr. Reddy Repurposed Drugs Product Offerings
Table 62. Dr. Reddy Repurposed Drugs Revenue (US$, Mn), (2017-2022)
Table 63. R-Pharma Corporate Summary
Table 64. R-Pharma Repurposed Drugs Product Offerings
Table 65. R-Pharma Repurposed Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Repurposed Drugs Segment by Type in 2021
Figure 2. Repurposed Drugs Segment by Application in 2021
Figure 3. Global Repurposed Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Repurposed Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Repurposed Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Repurposed Drugs Revenue in 2021
Figure 8. By Type - Global Repurposed Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Repurposed Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Repurposed Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Repurposed Drugs Revenue Market Share, 2017-2028
Figure 12. US Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Repurposed Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Repurposed Drugs Revenue Market Share, 2017-2028
Figure 24. China Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Repurposed Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Repurposed Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Repurposed Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Teva Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mylan Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bausch Health Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GSK Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. ChemRar Group Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Glenmark Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Fujifilm Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Dr. Reddy Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. R-Pharma Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)